We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bracco Acquires Acist Medical Systems

By HospiMedica staff writers
Posted on 12 Jul 2001
An important supplier of advanced injection systems for contrast media, Acist Medical Systems Inc. (Minneapolis, MN, USA), has been acquired by the Bracco Group (Milan, Italy), which occupies a prominent position in the field of diagnostic imaging. Terms were not disclosed. Acist expects 2001 sales to reach about US$20 million.

Acist currently has more than 500 of its injection systems installed throughout the world. Its devices allow fully automatic and controlled administration of fluids injected during x-ray procedures, increasing safety and reliability while reducing cost and execution time. These devices allow a doctor to pre-program pressure, volume, and flow of the fluids used in cardiac catheterization procedures, including contrast media.

The acquisition expands Bracco's line of products in the field of diagnostic imaging. It also fits with Bracco's overall acquisition strategy, begun in the late 1990s, with the purchase of a controlling interest in the Esaote Group and the buyback of Merck's share in Bracco. The company had sales of $900 million in 2000. "Acist will strengthen our integrated imaging products and systems portfolio, which ranges from tools used purely for diagnosis to systems used for interventional procedures and post-operative follow-up,” said Diana Bracco, CEO of Bracco.




Related Links:
Bracco
Pocket Fetal Doppler
CONTEC10C/CL
Medical Radiographic X-Ray Machine
TR30N HF
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Digital X-Ray Detector Panel
Acuity G4

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.